Reactive oxygen species from non-thermal gas plasma (CAP): implication for targeting cancer stem cells.

Autor: Babajani A; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran., Eftekharinasab A; Plasma Medicine Group, Plasma Research Institute, Kharazmi University, Tehran, Iran., Bekeschus S; ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489, Greifswald, Germany., Mehdian H; Plasma Medicine Group, Plasma Research Institute, Kharazmi University, Tehran, Iran., Vakhshiteh F; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. f.vakhshiteh@gmail.com., Madjd Z; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. majdjabari.z@iums.ac.ir.; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran. majdjabari.z@iums.ac.ir.

Publikováno v: Cancer cell international [Cancer Cell Int] 2024 Oct 22; Vol. 24 (1), pp. 344. Date of Electronic Publication: 2024 Oct 22.

Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy

Autor: Vakhshiteh F, Atyabi F, Ostad SN

Publikováno v: International Journal of Nanomedicine, Vol Volume 14, Pp 2847-2859 (2019)

Faezeh Vakhshiteh,1 Fatemeh Atyabi,1,2 Seyed Nasser Ostad3 1Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; 2Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University

Externí odkaz: https://doaj.org/article/4f1417b178074980adf2bfc36caa648b

Heterotypic tumor spheroids: a platform for nanomedicine evaluation.

Autor: Vakhshiteh F; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran., Bagheri Z; Department of Cell and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, 1983969411, Iran. ze_bagheri@sbu.ac.ir., Soleimani M; Department of Cell and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, 1983969411, Iran., Ahvaraki A; Department of Cell and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, 1983969411, Iran., Pournemat P; Department of Cell and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, 1983969411, Iran., Alavi SE; Faculty of Medicine, Frazer Institute, The University of Queensland, Brisbane, QLD, 4102, Australia., Madjd Z; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran.; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Publikováno v: Journal of nanobiotechnology [J Nanobiotechnology] 2023 Aug 02; Vol. 21 (1), pp. 249. Date of Electronic Publication: 2023 Aug 02.

Comparison of the safety and efficacy of fingolimod and tofacitinib in the zebrafish model of colitis.

Autor: Mousavi T; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Iran; Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Iran., Hassani S; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Iran; Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Iran. Electronic address: ShokoufeHasani@GMail.Com., Baeeri M; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Iran; Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Iran., Rahimifard M; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Iran; Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Iran., Vakhshiteh F; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran., Gholami M; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Iran; Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Iran., Ghafour-Broujerdi E; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Iran; Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Iran., Abdollahi M; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Iran; Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences (TUMS), Iran. Electronic address: Mohammad@TUMS.Ac.Ir.

Publikováno v: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association [Food Chem Toxicol] 2022 Dec; Vol. 170, pp. 113509. Date of Electronic Publication: 2022 Nov 04.

Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells.

Autor: Khabazian E; Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Vakhshiteh F; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Norouzi P; Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Fatahi Y; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Dinarvand R; Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Atyabi F; Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.; Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: Journal of drug targeting [J Drug Target] 2022 Jun; Vol. 30 (5), pp. 522-533. Date of Electronic Publication: 2022 Mar 28.